The clinical significance of cytomegaloviral inclusions in the allograft kidney

Transplantation

Volumn 67, Issue 1, 1999, Pages 98-103

  Kashyap, Randeep ^c   Shapiro, Ron ^c   Jordan, Mark ^c   Randhawa, Parmjeet S ^a,b,c  

^a Pathol Educ and Res Foundation   (United States)

^b PRESBYTERIAN UNIVERSITY HOSPITAL   (United States)

^c UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GANCICLOVIR; IMMUNOSUPPRESSIVE AGENT; MYCOPHENOLIC ACID; OKT 3; TACROLIMUS;

ADULT; AGED; ARTICLE; CREATININE BLOOD LEVEL; CYTOMEGALIC INCLUSION BODY DISEASE; CYTOMEGALOVIRUS INFECTION; DISEASE ASSOCIATION; FEMALE; GLOMERULOPATHY; GLOMERULUS CAPILLARY; HISTOPATHOLOGY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY ALLOGRAFT; KIDNEY ALLOGRAFT REJECTION; KIDNEY BIOPSY; MALE; PRIORITY JOURNAL;

EID: 0033556458     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199901150-00017     Document Type: Article

References (34)

1. Pillay D, Ali AA, Liu SF, Kops E, Sweny P, Griffiths PD. The prognostic significance of positive CMV cultures during surveillance of renal transplant recipients. Transplantation 1993; 56: 103.
2. Ranjan D, Burke G, Esquenazi V et al. Factors affecting the ten-year outcome of human renal allografts. Transplantation 1991; 51: 113.
3. Rubin RH, Cosimi AB, Hirsch MS, Herrin JT. Effects of antithymocyte globulin on cytomegalovirus infection in renal transplant recipients. Transplantation 1981; 31: 143.
4. Suwansirikul S, Rao N, Dowling JN, Ho M. Primary and secondary cytomegalovirus infection. Arch Intern Med 1977; 137: 1026.
5. Muldoon J, O'Riordan K, Rao S, Abecassis M. Ischemic colitis secondary to venous thrombosis: a rare presentation of cytomegalovirus vasculitis following renal transplantation. Transplantation 1996; 61: 1651
6. Cohen J, Hopkin J, Kurtz J. Infectious complications after renal transplantation. In: Morris PJ, ed. Kidney transplantation: principles and practice. Philadelphia: WB Saunders, 1994: 364.
7. Naraqi S, Jackson GG, Jonasson O, Rubenis M. Search for latent cytomegalovirus in renal allografts. Infect Immun 1978; 19: 699.
8. Ulrich W, Schlederer MP, Buxbaum P, et al. The histopathologic identification of CMV infected cells in biopsies of human renal allografts: an evaluation of 100 transplant biopsies by in situ hybridization. Pathol Res Pract 1986; 181: 739.
9. Solez K, Benediktsson H, Cavallo T, et al. Report of the Third Banff Conference on Allograft Pathology (July 20-24, 1995) on classification and lesion scoring in renal allograft pathology. Transplant Proc 1996; 28: 441.
10. Offner G. Treatment of acute rejection. In: Tejani AH, Fine RN, eds. Pediatric renal transplantation. New York: Wiley-Liss, 1994: 279.
11. Bitsch A, Kirchner H, Dennin R, et al. The long persistence of CMV DNA in the blood of renal transplant patients after recovery from CMV infection. Transplantation 1993; 56: 108.
12. Battegay EJ, Mihatsch MJ, Mazzucchelli L, et al. Cytomegalovirus and kidney. Clin Nephrol 1988; 30: 239.
13. Dittmer R, Harfmann P, Busch R, Stenger KO, Batge B, Arndt R. CMV infection and vascular rejection in renal transplant patients. Transplant Proc 1989; 21: 3600.
14. Pouteil-Noble C, Ecochard R, Landrivon G, et al. Cytomegalovirus infection: an etiological factor for rejection? A prospective study in 242 renal transplant patients. Transplantation 1993; 55: 851.
15. Waldman WJ, Knight DA, Adams PW, Orosz CG, Sedmak DD. In vitro induction of endothelial HLA class II antigen expression by cytomegalovirus-activated CD4+ T cells. Transplantation 1993; 56: 1504.
16. Ode-Hakim S, Kern F, Fieze E, et al. Association between CMV-related graft injury and circulating cytokine-producing CD8+ memory cells. Transplant Proc 1995; 27: 951.
17. Shapiro RS, Jordan ML, Scantlebury VP, et al. Randomized trial of FK 506/prednisone vs FK 506/azathioprine/prednisone after renal transplantation: preliminary report. Transplant Proc 1993; 25: 669.
18. Cameron J, Rigby RJ, Van Deth AG, Petrie JJB. Severe tubulo-interstitial disease in a renal allograft due to cytomegalovirus infection. Clin Nephrol 1982; 18: 321.
19. Payton D, Thorner P, Eddy A, Yeger H, Baumal R. Demonstration by light microscopy of cytomegalovirus on a renal biopsy of a renal allograft recipient: confirmation by immunohistochemistry and in situ hybridization. Nephron 1987; 47: 205.
20. Gnann JW, Ahlmen J, Svalander C, Olding L, Oldstone MBA, Nelson JA. Inflammatory cells in transplanted kidneys are infected by human cytomegalovirus. Am J Pathol 1988; 132: 239.
21. Shorr RI, Longo WL, Oberley TD, Bozdech MJ, Walker DL. Cytomegalovirus-associated tubulointerstitial nephritis in an allogeneic bone marrow transplant recipient. Ann Intern Med 1987; 107: 351.
22. Platt JL, Sibley RK, Michael AF. Interstitial nephritis associated with cytomegalovirus infection. Kidney Int 1985; 28: 550.
23. Lewis RM, Johnson PC, Golden D, Van Buren CT, Kerman RH, Kahan BD. The adverse impact of cytomegalovirus infection on clinical outcome in cyclosporine-prednisolone treated renal allograft recipients. Transplantation 1988; 45: 353.
24. Schnitzler MA, Woodward RS, Brennan DC, Spitznagel EL, Dunagan WC, Bailey TC. The effects of cytomegalovirus serology on graft and recipient survival in cadaveric renal kidney transplantation: implications for organ allocation. Am J Kidney Dis 1997; 29: 428.
25. Whelchel JD, Pass RF, Diethelm AG, Whitley RJ, Alford CA. Effect of primary and recurrent cytomegalovirus infections upon graft and patient survival after renal transplantation. Transplantation 1979; 28: 443.
26. Arbus GS, Hebert D. Impact of recipient age on renal allograft outcome. In: Tejani AH, Fine RN, eds. Pediatric renal transplantation. New York: Wiley-Liss, 1994: 165.
27. Cappel R, Hestermans O, Toussaint C, et al. Cytomegalovirus infection and graft survival in renal graft recipients. Arch Virol 1978; 56: 149.
28. Nadasdy T, Smith J, Laszik Z, Waner JL, Johnson LD, Silva FG. Absence of association between cytomegalovirus infection and obliterative transplant arteriopathy in renal allograft rejection. Mod Pathol 1994; 7: 289.
29. Beneck D, Greco MA, Feiner HD. Glomerulonephritis in congenital cytomegalic inclusion disease. Hum Pathol 1986; 17: 1054.
30. Chertow GM, Rennke HG, Curhan GC, Brady HR. Renal vasculitis with HIV seropositivity: potential manifestation of cytomegalovirus infection. Am J Kidney Dis 1997; 30: 428.
31. Hiki Y, Leong AS, Mathew TH, Seymour AE, Pascoe V, Woodroffe AJ. Typing of intraglomerular mononuclear cells associated with transplant glomerular rejection. Clin Nephrol 1986; 26: 244.
32. Rao KV, Hafner GP, Crary GS, Anderson WR, Crosson JT. De novo immunotactoid glomerulopathy of the renal allograft: possible association with cytomegalovirus infection. Am J Kidney Dis 1994; 24: 97.
33. Richardson WP, Colvin RB, Cheeseman SH, et al. Glomerulopathy associated with cytomegalovirus viremia in renal allografts. N Engl J Med 1981; 305: 57.
34. Birk PE, Chavers BM. Does cytomegalovirus cause glomerular injury in renal allograft recipients? J Am Soc Nephrol 1997; 8: 1801.